Royal London Asset Management LTD Hutchmed (China) LTD Transaction History

Royal London Asset Management LTD

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$8.59 - $20.77 $1.16 Million - $2.81 Million	-135,300 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$15.52 - $35.65 $6,208 - $14,260	400 Added 0.3%	135,300 $2.56 Million
Q4 2021 Oct 18, 2022	BUY	$28.89 - $35.33 $257,121 - $314,437	8,900 Added 7.06%	134,900 $4.72 Million
Q4 2021 Jan 18, 2022	BUY	$28.89 - $35.33 $257,121 - $314,437	8,900 Added 7.06%	134,900 $4.72 Million
Q3 2021 Oct 18, 2022	BUY	$35.66 - $42.94 $766,689 - $923,210	21,500 Added 20.57%	126,000 $4.61 Million
Q3 2021 Nov 02, 2021	BUY	$35.66 - $42.94 $766,689 - $923,210	21,500 Added 20.57%	126,000 $4.61 Million
Q2 2021 Oct 18, 2022	BUY	$23.7 - $39.27 $2.48 Million - $4.1 Million	104,500 New	104,500 $4.11 Million
Q2 2021 Jul 14, 2021	BUY	$23.7 - $39.27 $1.08 Million - $1.79 Million	45,600 Added 77.42%	104,500 $4.11 Million
Q1 2021 Oct 17, 2022	BUY	$27.01 - $36.8 $1.59 Million - $2.17 Million	58,900 New	58,900 $1.66 Million
Q1 2021 Apr 13, 2021	BUY	$27.01 - $36.8 $361,934 - $493,119	13,400 Added 29.45%	58,900 $1.66 Million
Q4 2020 Jan 29, 2021	BUY	$27.51 - $34.36 $327,369 - $408,884	11,900 Added 35.42%	45,500 $1.46 Million
Q4 2019 Feb 05, 2020	BUY	$17.17 - $25.95 $576,912 - $871,920	33,600 New	33,600 $871,000

6.88M

6.2K

1.1K

Ticker HCM
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 172,955,008
Market Cap $2.5B
Description
HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...

Get notified when there are updates to the investment portfolio of Royal London Asset Management LTD, based on Form 13F filings with the SEC.

Stay updated on Royal London Asset Management LTD with notifications on news.